Author： Sarrafizadeh R. Trese M.T.
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.3, 2000-03, pp. : 333-341
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Age-related macular degeneration therapies eyed up
Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. :
Neovascular Age-Related Macular Degeneration: Potential Therapies
By Chappelow Aimee V. Kaiser Peter K.
Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. :
Age-Related Macular Degeneration: Epidemiology and Optimal Treatment
By Lacour M.
Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. :
Treatment and Prevention of Age‐Related Macular Degeneration
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 1, 2004-03 ,pp. :